BGT vs CUV

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

BGT

BIOGENETEC FPO [BGT]

55MEDIUM

CUV

CLINUVEL FPO [CUV]

55MEDIUM

Score Breakdown

BGT CUV
Technical
62
71
Catalyst
51
52
Sentiment
50
50
Fundamental
41
79
Momentum
80
56
Risk Gate
34
40

Key Metrics

BGT Metric CUV
$10.7MMarket Cap$483.4M
126KAvg Volume (20d)113K
N/AShort Interest+8.2%
$0.06152-Week High$14.000
$0.01652-Week Low$9.310
+0.0%Daily Change+2.9%
$0.035Entry Price$9.910
-202.2%ROE+14.0%
N/AProfit Margin+33.8%

Active Signals

BGT Signals

●Stochastic is deep in oversold territory — bounce conditions forming
●Trading above the 200-day average — the long-term trend is on your side
●Critical cash runway (1.7 quarters)
●Strong revenue growth (+208%)
●Micro-cap ($5-20M) - high risk
●CANSLIM S: Tight float (35%)
●Not enough chatter to gauge sentiment — defaulting to neutral
●Sentiment is mixed — no strong consensus either way

CUV Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Bollinger Bands are tightening — volatility is coiling up for a potential breakout
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Moderate P/S ratio (5.0x)
●Piotroski F-Score strong (8/9, low-confidence approx)

Ask Scout AI to compare BGT and CUV in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
BGT Full Analysis → CUV Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).